1. Home
  2. MBIO vs POAI Comparison

MBIO vs POAI Comparison

Compare MBIO & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • POAI
  • Stock Information
  • Founded
  • MBIO 2015
  • POAI 2002
  • Country
  • MBIO United States
  • POAI United States
  • Employees
  • MBIO N/A
  • POAI N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • POAI Industrial Specialties
  • Sector
  • MBIO Health Care
  • POAI Health Care
  • Exchange
  • MBIO Nasdaq
  • POAI Nasdaq
  • Market Cap
  • MBIO 7.3M
  • POAI 9.7M
  • IPO Year
  • MBIO N/A
  • POAI N/A
  • Fundamental
  • Price
  • MBIO $2.80
  • POAI $1.62
  • Analyst Decision
  • MBIO Strong Buy
  • POAI Hold
  • Analyst Count
  • MBIO 1
  • POAI 1
  • Target Price
  • MBIO $100.00
  • POAI N/A
  • AVG Volume (30 Days)
  • MBIO 405.3K
  • POAI 2.7M
  • Earning Date
  • MBIO 03-10-2025
  • POAI 03-27-2025
  • Dividend Yield
  • MBIO N/A
  • POAI N/A
  • EPS Growth
  • MBIO N/A
  • POAI N/A
  • EPS
  • MBIO N/A
  • POAI N/A
  • Revenue
  • MBIO N/A
  • POAI $1,484,223.00
  • Revenue This Year
  • MBIO N/A
  • POAI N/A
  • Revenue Next Year
  • MBIO N/A
  • POAI $569.48
  • P/E Ratio
  • MBIO N/A
  • POAI N/A
  • Revenue Growth
  • MBIO N/A
  • POAI N/A
  • 52 Week Low
  • MBIO $2.40
  • POAI $0.55
  • 52 Week High
  • MBIO $74.50
  • POAI $3.76
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 29.74
  • POAI 62.46
  • Support Level
  • MBIO $2.40
  • POAI $1.37
  • Resistance Level
  • MBIO $3.04
  • POAI $1.58
  • Average True Range (ATR)
  • MBIO 0.65
  • POAI 0.13
  • MACD
  • MBIO 0.06
  • POAI -0.01
  • Stochastic Oscillator
  • MBIO 9.30
  • POAI 93.55

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: